Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 Virus

As a clinical setting in which local live biological therapy is already well established, non-muscle invasive bladder cancer (NMIBC) presents intriguing opportunities for oncolytic virotherapy. Coxsackievirus A21 (CVA21) is a novel intercellular adhesion molecule-1 (ICAM-1)-targeted immunotherapeuti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Ther Oncolytics
Main Authors: Annels, Nicola E., Arif, Mehreen, Simpson, Guy R., Denyer, Mick, Moller-Levet, Carla, Mansfield, David, Butler, Rachel, Shafren, Darren, Au, Gough, Knowles, Margaret, Harrington, Kevin, Vile, Richard, Melcher, Alan, Pandha, Hardev
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Gene & Cell Therapy 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6035483/
https://ncbi.nlm.nih.gov/pubmed/29989024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2018.02.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados